Literature DB >> 15570434

Mucolipin 1: endocytosis and cation channel--a review.

Gideon Bach1.   

Abstract

Mucolipidosis type IV (MLIV) is a neurodegenerative, recessive, lysosomal storage disorder characterized by psychomotor retardation and visual impairment due to various ophthalmologic abnormalities. MLIV is found in relatively high frequency in the Ashkenazi Jewish population. The disease is caused by mutations in the gene MCOLN1, which encodes the protein mucolipin 1 (MLN1), a member of the mucolipins family. MLN1 is a non-specific cation channel, and its putative structure attributes it to the TRP superfamily; thus, the gene is also referred as TRPML1. Over 16 MLIV-causing mutations, including two founder mutations in the Ashkenazi population, have been identified hitherto. Atypical increased lysosomal storage in MLIV is present in the cells of all patients. This accumulation is caused by an abnormal endocytosis process of the membrane components to late endosomes to the lysosomes, resulting in an apparent block in the traffic process in pre-lysosomal vacuoles with intraluminal pH of >5.0. MLN1 was localized in cultured cells to late endosomes and lysosomes. The exact function of this cation channel in the late stages of lysosomal maintenance is currently under study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570434     DOI: 10.1007/s00424-004-1361-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  49 in total

1.  Elevated lysosomal pH in Mucolipidosis type IV cells.

Authors:  G Bach; C S Chen; R E Pagano
Journal:  Clin Chim Acta       Date:  1999-02       Impact factor: 3.786

2.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

3.  Mucolipidosis type IV: abnormal transport of lipids to lysosomes.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

4.  Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV.

Authors:  M Zeigler; G Bach
Journal:  Clin Chim Acta       Date:  1986-06-15       Impact factor: 3.786

5.  Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway.

Authors:  Janice M LaPlante; John Falardeau; Mei Sun; Marie Kanazirska; Edward M Brown; Susan A Slaugenhaupt; Peter M Vassilev
Journal:  FEBS Lett       Date:  2002-12-04       Impact factor: 4.124

6.  Review article: mucolipidosis IV.

Authors:  B F Crandall; M Philippart; W J Brown; D A Bluestone
Journal:  Am J Med Genet       Date:  1982-07

7.  Mucolipidosis IV, a sialolipidosis due to ganglioside sialidase deficiency.

Authors:  L Caimi; G Tettamanti; B Berra; F Omodeo Sale; C Borrone; R Gatti; P Durand; J J Martin
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

8.  Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy.

Authors:  I Tellez-Nagel; I Rapin; T Iwamoto; A B Johnson; W T Norton; H Nitowsky
Journal:  Arch Neurol       Date:  1976-12

9.  The neurogenetics of mucolipidosis type IV.

Authors:  G Altarescu; M Sun; D F Moore; J A Smith; E A Wiggs; B I Solomon; N J Patronas; K P Frei; S Gupta; C R Kaneski; O W Quarrell; S A Slaugenhaupt; E Goldin; R Schiffmann
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

10.  Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.

Authors:  M T Bassi; M Manzoni; E Monti; M T Pizzo; A Ballabio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-09-29       Impact factor: 11.025

View more
  32 in total

1.  Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy.

Authors:  David A Zeevi; Shaya Lev; Ayala Frumkin; Baruch Minke; Gideon Bach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

2.  Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium.

Authors:  Weiqun Yu; Warren G Hill; Gerard Apodaca; Mark L Zeidel
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

3.  Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1.

Authors:  Kartik Venkatachalam; Thomas Hofmann; Craig Montell
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

Review 4.  TRP channels.

Authors:  Kartik Venkatachalam; Craig Montell
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

5.  N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Jakub Sikora; Ladislav Kuchar; Jana Ledvinova; Yulia Grishchuk; Shirley L Wang; Kostantin Dobrenis; Steven U Walkley
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

Review 6.  Molecular physiology and pathophysiology of lysosomal membrane transporters.

Authors:  C Sagné; B Gasnier
Journal:  J Inherit Metab Dis       Date:  2008-04-15       Impact factor: 4.982

Review 7.  Transient receptor potential channelopathies.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2010-02-04       Impact factor: 3.657

Review 8.  TRP channels and Ca2+ signaling.

Authors:  Baruch Minke
Journal:  Cell Calcium       Date:  2006-06-27       Impact factor: 6.817

9.  Constitutive activity of the human TRPML2 channel induces cell degeneration.

Authors:  Shaya Lev; David A Zeevi; Ayala Frumkin; Vered Offen-Glasner; Gideon Bach; Baruch Minke
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

10.  Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells.

Authors:  Kartik Venkatachalam; A Ashleigh Long; Rebecca Elsaesser; Daria Nikolaeva; Kendal Broadie; Craig Montell
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.